Skip to main content
. 2022 Jan 11;12(6):2790–2807. doi: 10.1016/j.apsb.2022.01.002

Table 2.

In vitro COX-1/COX-2 inhibition (IC50, μmol/L), selectivity index, ulcerogenic evaluation for compounds 1821, and standard agents.

Compd. COX-1a COX-2a COX-2 selectivityb Ulcer index
18 4.52 0.42 10.76 1.22
19 6.74 0.62 10.87 3.02
20 4.52 0.52 8.69 2.60
21 7.86 0.86 9.14 2.61
Celecoxib 7.23 0.84 8.61 2.93
Ibuprofen 20.25
a

The result (IC50, μmol/L) is the mean of three determinations acquired using a COX fluorescent inhibitor screening assay kit (Cayman Chemical, MI, USA).

b

COX-2 selectivity index (COX-1 IC50/COX-2 IC50).